Skip to main
EBS
EBS logo

Emergent BioSolutions (EBS) Market Capitalization Overview

Market Cap: $339.24M as of Jun 13, 2025

$339.24M
Past Month+$33.11M (10.82%)
As of Jun 13, 2025, Emergent BioSolutions (EBS) has a market capitalization of $339.24M. Over the past 30 days, its market cap has increased by 27.91%, while in the last 12 months, it has decreased by -34.51%.

Market capitalization represents the total value of Emergent BioSolutions as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Emergent BioSolutions (EBS) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Emergent BioSolutions (EBS) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Emergent BioSolutions (EBS) Market Cap History

DateMarket CapChange
Jun 2, 2025$341.96M+27.91%
May 1, 2025$267.34M+3.80%
Apr 1, 2025$257.56M-30.40%
Mar 3, 2025$370.08M-34.89%
Feb 3, 2025$568.40M+2.14%
Jan 2, 2025$556.48M+4.37%

Emergent BioSolutions (EBS) End of Year Market Cap History

DateMarket CapChange
2025$339.24M-34.51%
2024$518.01M+315.99%
2023$124.53M-78.87%
2022$589.18M-74.81%
2021$2.34B-50.75%
2020$4.75B

FAQs About Emergent BioSolutions (EBS) Market Cap

As of Jun 13, 2025, the market capitalization of Emergent BioSolutions (EBS) is $339.24M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Emergent BioSolutions’s market capitalization has increased by 10.82%, changing from $306.13M to $339.24M as of Jun 13, 2025.

In the last 3 months, Emergent BioSolutions’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Emergent BioSolutions’s market capitalization increased from $124.53M in January to $518.01M in December, reflecting a 315.99% change.

In the past five years, Emergent BioSolutions (EBS) has had a compound annual growth rate (CAGR) of -35.80% in market capitalization. This means its market cap has shrunk at an average rate of -35.80% per year.

Emergent BioSolutions (EBS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.